Pharmacokinetics of Lidocaine Hydrochloride Metabolized by CYP3A4 in Chinese Han Volunteers Living at Low Altitude and in Native Han and Tibetan Chinese Volunteers Living at High Altitude
Pharmacokinetics of Lidocaine Hydrochloride Metabolized by CYP3A4 in Chinese Han Volunteers Living at Low Altitude and in Native Han and Tibetan Chinese Volunteers Living at High Altitude
复制标题
CYP3A4代谢的盐酸利多卡因在低海拔汉族志愿者和高海拔汉族、藏族志愿者体内的药代动力学
作者:
张娟玲;朱俊博;姚星辰;段雅彬;周雪姣;杨梦;李向阳
To investigate the pharmacokinetics of lidocaine hydrochloride metabolized by cytochrome P450 3A4 (CYP3A4) in Chinese Han volunteers living at low altitude (LA) and in native Han and Tibetan Chinese volunteers living at high altitude, lidocaine hydrochloride 10 mg was given by intramuscular injection to 3 groups: Han volunteers living at LA, and native Han and Tibetan volunteers living at a high altitude. Blood samples were collected before the (baseline) study drug was given and at 0.25, 0.5, 1.0, 1.5, 2.0, 3.0, 4.0, 6.0, 8.0 h after study drug administration. Lidocaine hydrochloride in plasma was determined by RP-HPLC. Pharmacokinetics parameters of lidocaine hydrochloride showed that there were no significant difference between the native Han and Tibetan volunteers, but the t1/2 was 29.8 and 29.8% higher in 2 groups, respectively, than in the LA group. To study related mechanism, the effects of exposure to chronic high-altitude hypoxia (CHH) on the activity and expression of CYP3A1 were examined in rats. Rats were divided into LA, chronic moderate altitude hypoxia, and CHH groups. CHH caused significant decreases in the activity and protein and mRNA expression of rat CYP3A1 in vivo. This study found significant changes in the disposition of lidocaine hydrochloride in native healthy Tibetan and Han Chinese subjects living at a high altitude in comparison to healthy Han Chinese subjects living at LA, it might be due to significant decreases in the activity and protein and mRNA expression of CYP3A4 under CHH condition.
登录
查看更多内容
影响因子:
7.3
作者:
Fradette, C;Bleau, AM;du Souich, P
通讯作者:
du Souich, P
影响因子:
13.5
作者:
C. Reichel;A. Nacke;T. Sudhop;G. Wienkoop;C. Luers;C. Hahn;C. Pohl;U. Spengler;T. Sauerbruch
通讯作者:
C. Reichel;A. Nacke;T. Sudhop;G. Wienkoop;C. Luers;C. Hahn;C. Pohl;U. Spengler;T. Sauerbruch
影响因子:
3.7
作者:
Wang B;Zhang YB;Zhang F;Lin H;Wang X;Wan N;Ye Z;Weng H;Zhang L;Li X;Yan J;Wang P;Wu T;Cheng L;Wang J;Wang DM;Ma X;Yu J
通讯作者:
Yu J
影响因子:
3.2
作者:
Li, Xiang-Yang;Gao, Fen;Ge, Ri-Li
通讯作者:
Ge, Ri-Li
DOI:
--
发表时间:
2015-09
期刊:
Yao xue xue bao = Acta pharmaceutica Sinica
影响因子:
--
作者:
Juan-ling Zhang;Xiang-yang Li
通讯作者:
Juan-ling Zhang;Xiang-yang Li